NO173547C - Analogifremgangsmaate for fremstilling av terapeutisk aktive kinolonkarboksylsyrederivater - Google Patents

Analogifremgangsmaate for fremstilling av terapeutisk aktive kinolonkarboksylsyrederivater

Info

Publication number
NO173547C
NO173547C NO901274A NO901274A NO173547C NO 173547 C NO173547 C NO 173547C NO 901274 A NO901274 A NO 901274A NO 901274 A NO901274 A NO 901274A NO 173547 C NO173547 C NO 173547C
Authority
NO
Norway
Prior art keywords
preparation
carboxylic acid
acid derivatives
therapeutically active
analogous procedures
Prior art date
Application number
NO901274A
Other languages
English (en)
Norwegian (no)
Other versions
NO901274L (no
NO173547B (no
NO901274D0 (no
Inventor
Michael Schriewer
Klaus Grohe
Andreas Krebs
Uwe Petersen
Thomas Schenke
Ingo Haller
Karl Georg Metzger
Rainer Endermann
Hans-Joachim Zeiler
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag filed Critical Bayer Ag
Publication of NO901274D0 publication Critical patent/NO901274D0/no
Publication of NO901274L publication Critical patent/NO901274L/no
Publication of NO173547B publication Critical patent/NO173547B/no
Publication of NO173547C publication Critical patent/NO173547C/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/48Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C07D215/54Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3
    • C07D215/56Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3 with oxygen atoms in position 4
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/08Bridged systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Plural Heterocyclic Compounds (AREA)
NO901274A 1989-04-03 1990-03-20 Analogifremgangsmaate for fremstilling av terapeutisk aktive kinolonkarboksylsyrederivater NO173547C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE3910663A DE3910663A1 (de) 1989-04-03 1989-04-03 5-alkylchinoloncarbonsaeuren

Publications (4)

Publication Number Publication Date
NO901274D0 NO901274D0 (no) 1990-03-20
NO901274L NO901274L (no) 1990-10-04
NO173547B NO173547B (no) 1993-09-20
NO173547C true NO173547C (no) 1993-12-29

Family

ID=6377683

Family Applications (1)

Application Number Title Priority Date Filing Date
NO901274A NO173547C (no) 1989-04-03 1990-03-20 Analogifremgangsmaate for fremstilling av terapeutisk aktive kinolonkarboksylsyrederivater

Country Status (16)

Country Link
EP (1) EP0391132A1 (zh)
JP (1) JP3046035B2 (zh)
KR (1) KR0156245B1 (zh)
CN (1) CN1035945C (zh)
AU (1) AU638005B2 (zh)
CA (1) CA2013449C (zh)
DD (1) DD298400A5 (zh)
DE (1) DE3910663A1 (zh)
FI (1) FI901615A0 (zh)
HU (2) HUT58056A (zh)
IL (1) IL93954A0 (zh)
NO (1) NO173547C (zh)
NZ (1) NZ233142A (zh)
PH (1) PH27364A (zh)
PT (1) PT93639A (zh)
ZA (1) ZA902510B (zh)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4920120A (en) * 1988-01-25 1990-04-24 Warner-Lambert Company Antibacterial agents
MY105136A (en) * 1988-04-27 1994-08-30 Daiichi Seiyaku Co Optically active pyridonecarboxylic acid derivatives.
DD285601A5 (de) * 1988-07-15 1990-12-19 Bayer Ag,De Verfahren zur herstellung von 7-(1-pyrrolidinyl)-3-chinolon- und naphthyridoncarbonsaeure-derivaten
ES2079391T3 (es) * 1989-04-17 1996-01-16 Bayer Ag Procedimiento para la obtencion de 2,7-diazabiciclo(3.3.0)octanos.
US5241076A (en) * 1989-04-17 1993-08-31 Bayer Aktiengesellschaft 1,4-diazatricyclo [6.3.0.0]undecanes
US5177210A (en) * 1989-04-17 1993-01-05 Bayer Aktiengesellschaft Preparation of 2,7-diazabicyclo(3.3.0)octanes
WO1992021659A1 (en) * 1991-05-28 1992-12-10 Daiichi Pharmaceutical Co., Ltd. Pyridonecarboxylic acid derivative
DE4120646A1 (de) * 1991-06-22 1992-12-24 Bayer Ag 7-isoindolinyl-chinolon- und naphthyridoncarbonsaeure-derivate
TW209865B (zh) * 1992-01-10 1993-07-21 Bayer Ag
KR960003611B1 (ko) * 1992-07-23 1996-03-20 재단법인 한국화학연구소 신규한 디아자비시클로 알켄 유도체 및 그의 제조방법
DE4234078A1 (de) * 1992-10-09 1994-04-14 Bayer Ag Chinoloncarbonsäuren
DE4234330A1 (de) * 1992-10-12 1994-04-14 Bayer Ag Chinoloncarbonsäuren
NO301165B1 (no) * 1992-12-25 1997-09-22 Daiichi Seiyaku Co Bicykliske aminderivater og antibakterielle midler inneholdende disse
AU4272793A (en) * 1993-04-24 1994-11-21 Korea Research Institute Of Chemical Technology Novel quinolone carboxylic acid derivatives and process for preparing the same
DE4329600A1 (de) * 1993-09-02 1995-03-09 Bayer Ag Pyrido [1,2,3-d,e] [1,3,4] benzoxadiazinderivate
DE4339134A1 (de) * 1993-11-16 1995-05-18 Bayer Ag 1-(2-Fluorcyclopropyl)-chinolon- und -naphthyridoncarbonsäure-Derivate
DE4408212A1 (de) * 1994-03-11 1995-09-14 Bayer Ag 5-Vinyl- und 5-Ethinyl-chinolon- und -naphthyridon-carbonsäuren
DE19546249A1 (de) * 1995-12-12 1997-06-19 Bayer Ag Neue Kristallmodifikation des 1-Cyclopropyl-7-([S,S]-2,8-diazabicyclo[4,3,0]non-8-yl)-6-fluor-1,4-dihydro-8-methoxy-4-oxo-3-chinolincarbonsäure Hydrochlorid (CDCH), Verfahren zu dessen Herstellung und diese enthaltende pharmazeutische Zubereitungen
DE19633805A1 (de) * 1996-02-23 1997-08-28 Bayer Ag Gegenenenfalls substituierte 8-Cyan-l-cyclopropyl-7-(2,8-diazabicyclo-[4.3.0]-nonan-8-yl)-6-fluor-1,4-dihydro-4-oxo-3-chinolincarbonsäuren und ihre Derivate
ES2184060T3 (es) * 1996-02-23 2003-04-01 Bayer Ag Acidos 8-cian-1-ciclopropil-7-(2,8-diazabiciclo(4,3,0)-noman -8-il)-6-fluor-1,4-dihidro-4-oxo-3-quinolincarboxilicos, en caso dado substituidos, y sus derivados.
DE19652239A1 (de) 1996-12-16 1998-06-18 Bayer Ag Verwendung von 7-(2-Oxa-5,8-diazabicyclo[4.3.0]non-8-yl)-chinolon- und -naphthyridoncarbonsäure-Derivaten zur Therapie von Helicobacter-pylori-Infektionen und den damit assoziierten gastroduodenalen Erkrankungen
DE19854357A1 (de) * 1998-11-25 2000-05-31 Bayer Ag Semi-Hydrochlorid von 8-Cyan-1-cyclopropyl-7-(1S,6S-2,8-diazabicyclo/4.3.0/ -nonan-8-yl)-6-fluor-1,4-dihydro-4-oxo-3-chinolincarbonsäure
DE19854356A1 (de) * 1998-11-25 2000-05-31 Bayer Ag Kristallmodifikation A von 8-Cyan-1-cyclopropyl-7-(1S,6S-2,8-diazabicyclo-/4.3.0/nonan-8-yl)-6-fluor-1,4-dihydro-4-oxo-3-chinolincarbonsäure
DE19854355A1 (de) * 1998-11-25 2000-05-31 Bayer Ag Kristallmodifikation B von 8-Cyan-1-cyclopropyl-7-(1S, 6S-2,8-diazabicyclo-/4.3.O/nonan-8-yl)-6-fluor-1,4-dihydro-4-oxo-3-chinolincarbonsäure
JP2006504690A (ja) 2002-09-10 2006-02-09 ファイザー・プロダクツ・インク Cns及びその他の障害の治療に有用なジアザ二環式化合物
CN100410249C (zh) 2003-09-10 2008-08-13 杏林制药株式会社 7-(4-取代-3-环丙基氨基甲基-1-吡咯烷基)喹诺酮羧酸衍生物
US8222407B2 (en) 2007-05-24 2012-07-17 Kyorin Pharmaceutical Co., Ltd. Mutilin derivative having heterocyclic aromatic ring carboxylic acid structure in substituent at 14-position
CN101718743B (zh) * 2009-11-30 2013-03-20 宁波大学 一种混合导体致密扩散障型氧传感器的制备方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3522405A1 (de) * 1985-06-22 1987-01-02 Bayer Ag 1,8-verbrueckte 4-chinolon-3-carbonsaeuren, verfahren zu ihrer herstellung sowie diese enthaltende arzneimittel und ihre verwendung zur herstellung von arzneimitteln
DE3543513A1 (de) * 1985-12-10 1987-06-11 Bayer Ag Enantiomerenreine 1,8-verbrueckte 4-chinolon-3-carbonsaeuren, verfahren zu ihrer herstellung sowie diese enthaltende arzneimittel und ihre verwendung zur herstellung von arzneimitteln
DE3601567A1 (de) * 1986-01-21 1987-07-23 Bayer Ag 7-(azabicycloalkyl)-chinoloncarbonsaeure- und -naphthyridon-carbonsaeure-derivate
DE3702393A1 (de) * 1987-01-28 1988-08-11 Bayer Ag 8-cyano-1-cyclopropyl-1,4-dihydro-4-oxo- 3-chinolincarbonsaeuren, verfahren zu ihrer herstellung und diese enthaltende antibakterielle mittel
US5563138A (en) * 1987-04-16 1996-10-08 Otsuka Pharmaceutical Company, Limited Benzoheterocyclic compounds
US4920120A (en) * 1988-01-25 1990-04-24 Warner-Lambert Company Antibacterial agents

Also Published As

Publication number Publication date
JPH02289583A (ja) 1990-11-29
CA2013449C (en) 2001-01-02
CA2013449A1 (en) 1990-10-03
DE3910663A1 (de) 1990-10-04
HU912263D0 (en) 1991-12-30
NZ233142A (en) 1992-09-25
CN1035945C (zh) 1997-09-24
KR900016186A (ko) 1990-11-12
EP0391132A1 (de) 1990-10-10
NO901274L (no) 1990-10-04
ZA902510B (en) 1991-01-30
AU638005B2 (en) 1993-06-17
IL93954A0 (en) 1990-12-23
HU204811B (en) 1992-02-28
FI901615A0 (fi) 1990-03-30
CN1046162A (zh) 1990-10-17
DD298400A5 (de) 1992-02-20
HU902055D0 (en) 1990-08-28
NO173547B (no) 1993-09-20
KR0156245B1 (ko) 1998-11-16
NO901274D0 (no) 1990-03-20
HUT56563A (en) 1991-09-30
JP3046035B2 (ja) 2000-05-29
PT93639A (pt) 1990-11-20
HUT58056A (en) 1992-01-28
AU5231790A (en) 1990-10-04
PH27364A (en) 1993-06-21

Similar Documents

Publication Publication Date Title
NO173547C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive kinolonkarboksylsyrederivater
NO164418C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive naftyridin- og kinolin-karboksylsyre-forbindelser.
NO173546C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 7-amino-1-cyklopropyl-6,8-dihalogen-1,4-dihydro-4-okso-3-kinolinkarboksylsyrer
NO173545C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive kinazolinderivater
NO179584C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive 2-acylaminotiazoler
NO162560C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive naftyridin-, kinolin- og benzoksazin-karboksylsyrer.
NO864425D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive heterocyklyloksoftalazinyl-eddiksyre-derivater.
NO178619C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive di-t-butylfenoler
NO176605C (no) Analogifremgangsmåte til fremstilling av terapeutisk aktive 7-(1-azetidinyl)-1,4-dihydro-4-okso-3-kinolinkarboksylsyrederivater
NO175978C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive bis-aza-bicykliske forbindelser
NO171214C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive pyridonkarboksylsyrederivater
NO893270D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive tetrahydropyridineddiksyrederivater.
NO176713C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive 4-aminopyridinderivater
NO895199D0 (no) Analogifremgangsmaate for fremstilling av terapeutisk virksomme kinolinsystemforbindelser.
NO802087L (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive karboksylsyrederivater
NO812686L (no) Fremgangsmaate for fremstilling av kinolinkarboksylsyrederivater
NO173784C (no) Anaslogifremgangsmaate for fremstilling av terapeutisk aktive tieno-tri-azolo-diazepinderivater
NO173607C (no) Analogifremgangsmaate for fremstilling av nye terapeutisk aktive tienotriazolo-diazepin-derivater
NO174773C (no) Fremgangsmåte for fremstilling av chinolonkarboksylsyrer
NO178698C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive glycerolderivater
FI890723A0 (fi) Menetelmä kinoliinikarboksyylihappojohdannaisten valmistamiseksi
NO174203C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive
NO174053C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive R(-) 3-kinuklidinol-derivater
NO173606C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive tieno- triazolo-diazepin-derivater
NO171016C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive quinolin-derivater

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees

Free format text: LAPSED IN SEPTEMBER 2002